Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19)

Cited by (835)

Items 801–835 of 835

1. Lineage-specific neutralising antibodies after SARS-CoV-2 mild disease. Immune boosting effect of vaccination
   Carlos Daviña‐Núñez, Sonia Pérez‐Castro, Jorge-Julio Cabrera-Alvargonzalez, Elena Gonzalez-Alonso, Sergio Silva-Bea, Miriam Rodriguez-Perez, Maria del Pilar Figueroa-Lamas, Alexandre Pérez‐González, Víctor del Campo, Almudena Rojas et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
2. Uncertainty in COVID-19 transmission could undermine our ability to predict long COVID
   Alexander B. Beams, David J. D. Earn, Caroline Colijn · 2024 · Journal of The Royal Society Interface
3. Rapid Recovery From SARS-CoV-2 Infection Among Immunocompromised Children Despite Limited Neutralizing Antibody Response: A Virologic and Sero-Immunologic Analysis of a Single-Center Cohort
   Doo Ri Kim, Byoung Kwon Park, Jin Yang Baek, Areum Shin, Ji Won Lee, Hee Young Ju, Hee Won Cho, Keon Hee Yoo, Ki Woong Sung, Chae-Hong Jeong et al. · 2024 · Journal of Korean Medical Science
4. Predicting persistent SARS-CoV-2 shedding in immunocompromised patients: a probability-based approach
   Euijin Chang, Jun-Won Kim, Choi‐Young Jang, Ji Yeun Kim, Sung‐Woon Kang, Seongman Bae, Jiwon Jung, Min Jae Kim, Yong Pil Chong, Sang‐Oh Lee et al. · 2025 · Scandinavian Journal of Infectious Diseases
5. Freeze-Drying as a Novel Concentrating Method for Wastewater Detection of SARS-CoV-2
   Rui Dong, Elizabeth Noriega Landa, Hugues Ouellet, Wen‐Yee Lee, Chuan Xiao · 2026 · Environmental Science & Technology
6. Impact of non-pharmacological interventions on the first wave of COVID-19 in Portugal 2020
   Dinis B. Loyens, Constantino Caetano, Carlos Matias Dias · 2025 · Heliyon
7. Subgenomic RNA and Limited Cross-Reactive Neutralising Antibodies Point to Potential Improvements in SARS-CoV-2 Clinical Handling
   Carlos Daviña‐Núñez, Sonia Pérez‐Castro, Jorge Julio Cabrera, Elena Gonzalez-Alonso, Sergio Silva-Bea, Miriam Rodriguez-Perez, Maria del Pilar Figueroa-Lamas, Alexandre Pérez‐González, Víctor del Campo, Almudena Rojas et al. · 2025 · International Journal of Molecular Sciences
8. Dynamic contagion potential framework for optimizing infection control in healthcare
   Alexandra Fedrigo, Mohamed Nassar, Jennifer R. Bail, Antonia Bates-Ford, Satyaki Roy · 2025 · Frontiers in Public Health
9. Evaluating COVID-19 vaccination policy in Québec (Canada) using a data-driven dynamic transmission model
   Samuel Torres-Florez, Jorge Luis Flores Anato, Jiahuan Helen He, Vicente Garrido Portilla, Yichen Wu, Mathieu Maheu‐Giroux, Étienne Racine, Caroline E. Wagner · 2025 · PLoS Computational Biology
10. COVID-19 and type 2 diabetes mellitus—Interrelation, outcome, and therapeutic strategies
    Iliyan Todorov, Yoanna Radeva, Kiril Borislavov Karaivanov · 2025 · Scripta Scientifica Medica
11. Comparative Assessment of Viral Load Retention in Surgical and Fabric Masks Worn by COVID-19 Patients
    Cristiane M. Eller, Milena De Paula Rebello, Andreza Lemos Salvio, Emanuelle S. R. F. Silva, Viní­cius Silva Belo, Elba Regina Sampaio de Lemos, Marta Giovanetti, José Júnior França de Barros, Marco Aurélio Pereira Horta · 2025 · Viruses
12. Additional file 1 of Prolonged SARS-CoV-2 infection following rituximab treatment: clinical course and response to therapeutic interventions correlated with quantitative viral cultures and cycle threshold values
    Thornton, Christina S., Kevin Huntley, Byron Michael Berenger, Michael Bristow, Evans, David H., Kevin Fonseca, Angela D. Franko, Mark R. Gillrie, Lin, Yi-Chan, Marcus Povitz et al. · 2022 · Figshare
13. Additional file 1 of Head-to-head comparison of the accuracy of saliva and nasal rapid antigen SARS-CoV-2 self-testing: cross-sectional study
    Ewoud Schuit, Roderick P Venekamp, Irene K Veldhuijzen, Wouter van den Bijllaardt, Pas, Suzan D., Joep Stohr, Esther B Lodder, Marloes Hellwich, Richard Molenkamp, Zsὁfia Iglὁi et al. · 2022 · Figshare
14. Additional file 1 of Human ACE2 protein is a molecular switch controlling the mode of SARS-CoV-2 transmission
    Yang, Chao-Fu, Liao, Chun-Che, Hsu, Hung-Wei, Liang, Jian-Jong, Chang, Chih-Shin, Ko, Hui-Ying, Chang, Rue-Hsin, Tang, Wei-Chun, Chang, Ming-Hao, Wang, I-Hsuan et al. · 2024 · Figshare
15. Additional file 2 of Ultrastructural study confirms the formation of single and heterotypic syncytial cells in bronchoalveolar fluids of COVID-19 patients
    Chaudhary, Shikha, Ravi Prakash Yadav, Kumar, Shailendra, Yadav, Subhash Chandra · 2023 · Figshare
16. Additional file 1 of COVID-19 in pediatric cancer patients is associated with treatment interruptions but not with short-term mortality: a Polish national study
    Jadwiga Węcławek‐Tompol, Zuzanna Zakrzewska, Olga Gryniewicz–Kwiatkowska, Filip Pierlejewski, Ewa Bień, Agnieszka Zaucha‐Prażmo, Olga Zając‐Spychała, Anna Szmydki‐Baran, Agnieszka Joanna Mizia-Malarz, Wioletta Bal et al. · 2021 · Figshare
17. Additional file 1 of Ultrastructural study confirms the formation of single and heterotypic syncytial cells in bronchoalveolar fluids of COVID-19 patients
    Shikha Chaudhary, Ravi Prakash Yadav, Kumar, Shailendra, Yadav, Subhash Chandra · 2023 · Figshare
18. Additional file 2 of Human ACE2 protein is a molecular switch controlling the mode of SARS-CoV-2 transmission
    Yang, Chao-Fu, Liao, Chun-Che, Hsu, Hung-Wei, Liang, Jian-Jong, Chang, Chih-Shin, Ko, Hui-Ying, Chang, Rue-Hsin, Tang, Wei-Chun, Chang, Ming-Hao, Wang, I-Hsuan et al. · 2024 · Figshare
19. Additional file 3 of Human ACE2 protein is a molecular switch controlling the mode of SARS-CoV-2 transmission
    Yang, Chao-Fu, Liao, Chun-Che, Hsu, Hung-Wei, Liang, Jian-Jong, Chang, Chih-Shin, Ko, Hui-Ying, Chang, Rue-Hsin, Tang, Wei-Chun, Chang, Ming-Hao, Wang, I-Hsuan et al. · 2024 · Figshare
20. Comparing Cross‐Sectional and Longitudinal Study Designs for Accurate Viral Dynamics Estimation: Insights From the NBA Cohort Data
    Jihyeon Kim, Hyeongki Park, Hoong Kai Chua, Yuqian Wang, Shingo Iwami, Yong Dam Jeong, Koya Ariyoshi, Po Ying Chia, Barnaby Edward Young, Matthew E. Cove et al. · 2026 · Journal of Medical Virology
21. Coordinated immune response distinguishes duration of SARS-CoV-2 viral particle shedding in humans
    Daniel J. Schuster, Shuying S. Li, Dieter Mielke, Kelly Seaton, Caroline Brackett, Kan Li, Xiaoying Shen, Martina S. Wesley, Nathan Eisel, Nicole L. Yates et al. · 2026 · iScience
22. T immune responses to SARS-CoV-2 : identification of the immunogenic region associated with protection against infection
    Jean‐Eudes Fahrner · 2021 · theses.fr (ABES)
23. Dynamique de la réponse immunitaire au cours du traitement par anticorps bloquant PD-1 dans le cancer : mécanismes et recherche de biomarqueurs
    Anne‐Gaëlle Goubet · 2021
24. Identification of Biomarkers Associated With the Combination of Immunotherapy and Anti-Angiogenic Drugs in the Treatment of Mesothelioma : Translational Analyses of the PEMBIB Clinical Trial Combining the Anti-PD1 Monoclonal Antibody Embrolizumab and the Anti-Angiogenic Tyrosine Kinase Inhibitor Nintedanib
    François‐Xavier Danlos · 2021
25. Étude des mécanismes d’action de nouveaux inhibiteurs de coronavirus humains
    Thomas Meunier · 2021
26. Prise en charge d’une infection virale chronique (BK polyomavirus) et d’une infection virale aigue (SARS-CoV-2) dans une population de transplantés rénaux
    Iliès Benotmane · 2022 · theses.fr (ABES)
27. Diagnostic Value and Outcomes of Systematic SARS-CoV-2 Screening in Asymptomatic Patients
    Marvin Weiss, Pascal Urwyler, Matthias von Rotz, Richard Küehl, Sabine Kuster, Isabelle Vock, Lisandra Aguilar‐Bultet, Fabian Christoph Franzeck, Claudia Bagutti, Katharina Rentsch et al. · 2026 · JAMA Network Open
28. Coévolution de la balance fonctionnelle de l’hémagglutinine et la neuraminidase chez les virus influenza de type A
    Grégory Quéromès · 2023
29. Challenges around current implementation of two novel diagnostic tools for SARS-CoV-2 virus, to determine the timing of de-isolation of COVID-19 patients in the ICU
    Andrea Peeters, Daisy P. De Bruijn‐Geraets, Ghislaine A. P. G. van Mastrigt, Stephanie M C Ament, Bas C. T. van Bussel, Stefan H. M. Gorissen, Petra F. G. Wolffs, Inge H. M. van Loo, Tom Schoenmakers, Wilhelmine P.H.G. Verboeket‐van de Venne et al. · 2026 · Journal of Clinical Virology Plus
30. Using Animal Models to Inform Pandemic to Endemic Transition of COVID-19 in Humans
    Sarah Mullin, Susan R Compton, Sylvester Ibemgbo, Caroline Zeiß · 2026 · Sustainable development goals series
31. Heterogeneity of Airborne Virus Transmission in the Built Environment: A Narrative Review
    Yizhi Zhang, Kathryn Krupinsky, Adam S. Lauring, Linsey C. Marr · 2026 · Pathogens and Immunity
32. Baroreflex-dependent Cardiovascular Autonomic Reactivity is Deranged in Young Adult Mild COVID-19 Survivors
    Ayan Roy, Dinu S. Chandran, Ashok Kumar Jaryal, Manish Soneja, Ambuj Roy, Kishore Kumar Deepak · 2026 · Annals of Neurosciences
33. The impact of the distributions of the latent and infectious periods on epidemic dynamics
    Paulo Cesar Ventura, Allisandra G. Kummer, Yong-Dam Jeong, Shreeya Mhade, Shingo Iwami, Stefano Merler, Hongjie Yu, Keisuke Ejima, Maria Litvinova, Marco Ajelli · 2026 · Research Square
34. Efficient host transmission of measles virus: disentangling misconceptions from established findings
    Angela Liu, Patrick L. Sinn · 2026 · Microbiology and Molecular Biology Reviews
35. Phagocytosis of SARS-CoV-2 nucleocapsid- and RNA-containing immune complexes drives inflammatory cytokine production and endothelial dysfunction
    Johannes S. Gach, Daniel Kim, Khoa Vu, Michaela Ellen Marshall, Christopher Cachay, Aminah A. Rangwala, Gius Kerster, Delia F. Tifrea, Eric M. Pearlman, Matthew Zahn et al. · 2026 · PLoS Pathogens